A US advisory panel to the Food and Drug Administration (FDA) said that the available evidence doesn’t show that MDMA therapy for post-traumatic stress disorder (PTSD) is effective. It also said that its benefits outweigh its risks. There are two FDA-approved PTSD treatments for the condition, one of which is MDMA.